Filing Details
- Accession Number:
- 0001640455-18-000072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-18 18:24:16
- Reporting Period:
- 2018-06-15
- Accepted Time:
- 2018-06-18 18:24:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1640455 | Jounce Therapeutics Inc. | JNCE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604646 | M Hugh Cole | C/O Jounce Therapeutics, Inc. 780 Memorial Drive Cambridge MA 02139 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-15 | 1,900 | $7.84 | 1,900 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
